지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2020.1
- 수록면
- 187 - 195 (9page)
이용수
초록· 키워드
오류제보하기
Background/Aims: Acute exacerbations of chronic hepatitis B (CHB-AEs) are common in endemic areas and are often presumed to be acute hepatitis B (AHB) due to their similarities in clinical and serological pictures, presenting a major diagnostic dilemma. This study aimed to identify laboratory markers for differentiating between the two groups, and to establish the cut-off value for significant markers. Methods: A retrospective analysis of records was conducted for patients who presented with clinical features of acute hepatitis along with hepatitis B surface antigen (HBsAg) and IgM antibody to hepatitis B core antigen (IgM anti-HBc) positivity from May 2015 to May 2017. A total of 172 patients were enrolled and grouped as AHB (n=89) and CHB-AE (n=83) based on their history of hepatitis B virus infection and duration of HBsAg persistence. Virological and biochemical parameters were analyzed and compared. Cut-off values, sensitivity, and specificity of the variables were calculated. Results: The median value of signal by cut-off (S/Co) ratio for IgM anti-HBc was significantly higher in AHB group (30.44) compared to CHB-AE group (8.63) with a sensitivity and specificity of 97% and 84%, respectively, at a cut-off of 20.5 (P<0.01). The mean international normalized ratio (INR) was significantly greater in CHB-AE (1.88±1.24) group compared to AHB group (1.62±0.17) with a sensitivity and specificity of 57.9% and 45.1%, respectively, at a cut-off value of 1.27. Conclusions: A value of 20.5 S/Co of IgM anti-HBc and 1.27 INR could be helpful in differentiating between AHB and CHB-AE.
목차
등록된 정보가 없습니다.
참고문헌 (31)
참고문헌 신청
World Health Organization (WHO) / Hepatitis B. World health Organization Global hepatitis report 2017 / WHO web site
Lavanchy D / 2004 / Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures / J Viral Hepat 11:97~107
Puri P / 2014 / Tackling the hepatitis B disease burden in India / J Clin Exp Hepatol 4:312~319
Maruyama T / 1994 / Distinguishing between acute and symptomatic chronic Hepatitis B virus infection / Gastroenterology 106:1006~1015
Maruyama T / 1993 / Serology of acute exacerbation in chronic hepatitis B virus infection / Gastroenterology 105:1141~1151
Lavanchy D / 2004 / Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures / J Viral Hepat 11:97~107
Puri P / 2014 / Tackling the hepatitis B disease burden in India / J Clin Exp Hepatol 4:312~319
Maruyama T / 1994 / Distinguishing between acute and symptomatic chronic Hepatitis B virus infection / Gastroenterology 106:1006~1015
Maruyama T / 1993 / Serology of acute exacerbation in chronic hepatitis B virus infection / Gastroenterology 105:1141~1151
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Should physicians go out of the way to differentiate between acute hepatitis B and acute exacerbation of chronic hepatitis B?
Clinical and Molecular Hepatology
2020 .01
-
A challenge in distinguishing between acute hepatitis B and acute exacerbation of chronic hepatitis B
Clinical and Molecular Hepatology
2020 .01
-
Acute hepatitis A, B and C but not D is still prevalent in Mongolia: a time trend analysis
Clinical and Molecular Hepatology
2017 .06
-
The Epidemiology of Hepatitis B Virus Infection in Korea: 15-Year Analysis
Journal of Korean Medical Science
2024 .01
-
Comparative Analysis of Liver Injury-Associated Cytokines in Acute Hepatitis A and B
Yonsei Medical Journal
2016 .01
-
Estimated impact of the national hepatitis B immunization program on acute viral hepatitis B among adolescents in Republic of Korea
Osong Public Health and Research Persptectives
2023 .04
-
Hepatitis B Surface Antigen Quantification across Different Phases of Chronic Hepatitis B Virus Infection Using an Immunoradiometric Assay
Gut and Liver
2015 .01
-
De novo hepatitis B virus infection after liver transplantation in hepatitis B core-positive recipients using hepatitis B core-negative grafts
한국간담췌외과학회 학술대회지
2015 .09
-
Quantitative Hepatitis B Surface Antigen, the Trustworthy Biomarker for Functional Cure of Chronic Hepatitis B
Gut and Liver
2023 .03
-
Current and future strategies for the treatment of chronic hepatitis C
Clinical and Molecular Hepatology
2021 .01
-
Prevalence of Hepatitis B Virus and HIV Co-infection in Korea
JOURNAL OF BACTERIOLOGY AND VIROLOGY
2016 .12
-
Evaluation of the acute hepatitis B surveillance system in the Republic of Korea following the transition to mandatory surveillance
Osong Public Health and Research Persptectives
2024 .08
-
Acute Viral Hepatitis A with Cholestatic Hepatitis Treated with Traditional Korean Medicine : A Case Report
대한한의학회지
2015 .12
-
Evaluation of the histological scoring systems of autoimmune hepatitis: A significant step towards the optimization of clinical diagnosis
Clinical and Molecular Hepatology
2024 .04
-
2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C
Clinical and Molecular Hepatology
2018 .01
-
Chronic Hepatitis C Virus Infection, Why Not Treat Now?
대한류마티스학회지
2018 .01
-
Is the Prevalence of Chronic Hepatitis B Really Increasing in Korea?
Journal of Korean Medical Science
2024 .01
-
The factor that improve liver stiffness in patients with chronic hepatitis B
Clinical and Molecular Hepatology
2015 .01
-
Cross-Reactivity of Disease-Specific Antibody Assays for the Detection of Current Infections: With Potentially Interfering Substances of Other Infections
Journal of Laboratory Medicine And Quality Assurance
2022 .03
-
Another oral antiviral treatment, but still far away from hepatitis B virus cure
Clinical and Molecular Hepatology
2021 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0